Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 8Breast 6Genitourinary 5Tumor-Agnostic 3Other 3Lymphoid 3Thoracic 2Sarcoma 2Head & Neck 2Other hematologic neoplasm 1Gynecologic 1Endocrine 1CNS 1

Conditions

Neoplasms 3

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Electroacupuncture × Tumor-Agnostic × Clear all
NCT06340906 2026-02-13

Electroacupuncture in Symptom Management After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

University of California, Irvine

Phase NA Active not recruiting
20 enrolled
Tumor-Agnostic

Neoplasms

NCT05283577 2026-01-23

EAST

University of California, Irvine

Phase NA Active not recruiting
70 enrolled
Tumor-Agnostic

Neoplasms

NCT06891521 2025-03-24

Electroacupuncture for Preventing Adverse Events of Cancer Immunotherapy

Qinghai Red Cross Hospital

Phase 2 Not yet recruiting
123 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡